Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
George Dranitsaris, Xiaofu Zhu, Georges Adunlin & Mark D Vincent. (2018) Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs. Expert Review of Pharmacoeconomics & Outcomes Research 18:4, pages 351-357.
Read now
Read now
Surinder K. Sharma & Kenneth D. Bagshawe. (2017) Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination. Expert Opinion on Biological Therapy 17:1, pages 1-13.
Read now
Read now
Grazyna Lipowska-Bhalla, Ester Fagnano, Timothy M. Illidge & Eleanor J. Cheadle. (2016) Improving therapeutic activity of anti-CD20 antibody therapy through immunomodulation in lymphoid malignancies. Leukemia & Lymphoma 57:6, pages 1269-1280.
Read now
Read now
Articles from other publishers (34)
Martina Catalano, Giandomenico Roviello, Ilaria Camilla Galli, Raffaella Santi & Gabriella Nesi. (2022) Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge. Frontiers in Medicine 9.
Crossref
Crossref
Iman M. Talaat, Noha M. Elemam, Shroque Zaher & Maha Saber-Ayad. (2022) Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment. Frontiers in Medicine 9.
Crossref
Crossref
Erminia Romano, Jamie Honeychurch & Timothy M. Illidge. (2021) Radiotherapy–Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery?. Cancers 13:3, pages 457.
Crossref
Crossref
Francesco Longo, Francesco Perri, Francesco Caponigro, Giuseppina Della Vittoria Scarpati, Agostino Guida, Ettore Pavone, Corrado Aversa, Paolo Muto, Mario Giuliano, Franco Ionna & Raffaele Solla. (2020) Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?. Cancers 12:10, pages 2781.
Crossref
Crossref
Dhruv Kumar, Neelam Sharma-Walia, Sonia Kapoor & Simran Tandon. 2020. NanoBioMedicine. NanoBioMedicine
35
65
.
Ajaz Bulbul & Emilio Araujo-Mino. (2019) Reasoning the effect of immunotherapy after chemoradiation in the PACIFIC trial. Future Oncology 15:1, pages 81-94.
Crossref
Crossref
Héctor Randhall Callata-Carhuapoma & Jesús García-Foncillas López. 2019. Textbook of Gastrointestinal Oncology. Textbook of Gastrointestinal Oncology
465
477
.
Uma Prabhakar, Yalia Jayalakshmi & C. Katherine Wang. 2019. Nanotheranostics for Cancer Applications. Nanotheranostics for Cancer Applications
33
66
.
Tariq Nadeem, Mohsin Ahmad Khan, Bushra Ijaz, Nadeem Ahmed, Zia ur Rahman, Muhammad Shahzad Latif, Qurban Ali & Muhammad Adeel Rana. (2018) Glycosylation of Recombinant Anticancer Therapeutics in Different Expression Systems with Emerging Technologies. Cancer Research 78:11, pages 2787-2798.
Crossref
Crossref
Natalia Aptsiauri, Francisco Ruiz-Cabello & Federico Garrido. (2018) The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses. Current Opinion in Immunology 51, pages 123-132.
Crossref
Crossref
Torbjörn Ramqvist, Anders Näsman, Bo Franzén, Cinzia Bersani, Andrey Alexeyenko, Susanne Becker, Linnea Haeggblom, Aeneas Kolev, Tina Dalianis & Eva Munck-Wikland. (2018) Protein Expression in Tonsillar and Base of Tongue Cancer and in Relation to Human Papillomavirus (HPV) and Clinical Outcome. International Journal of Molecular Sciences 19:4, pages 978.
Crossref
Crossref
Yu. A. Ragulin. (2018) The combination of immunotherapy and radiation therapy for non-small cell lung cancer. Onkologiya. Zhurnal imeni P.A.Gertsena 7:5, pages 90.
Crossref
Crossref
Jennifer Moy & Robert L. Ferris. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
365
396
.
Sheila Jalalat, Corin Agoris, Neil Alan Fenske & Basil Cherpelis. 2018. Melanoma. Melanoma
591
604
.
Jamie Honeychurch & Timothy M. Illidge. (2018) The influence of radiation in the context of developing combination immunotherapies in cancer. Therapeutic Advances in Vaccines and Immunotherapy 5:6, pages 115-122.
Crossref
Crossref
E J Cheadle, G Lipowska-Bhalla, S J Dovedi, E Fagnano, C Klein, J Honeychurch & T M Illidge. (2016) A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells. Leukemia 31:7, pages 1611-1621.
Crossref
Crossref
C Fitzgerald & James Paul O'Neill. (2017) High-risk Cutaneous Squamous Cell Carcinoma. International Journal of Head and Neck Surgery 8:2, pages 37-44.
Crossref
Crossref
Jessica M. Moskovitz, Jennifer Moy, Tanguy Y. Seiwert & Robert L. Ferris. (2017) Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options. The Oncologist 22:6, pages 680-693.
Crossref
Crossref
Barbara Banelli, Antonio Daga, Alessandra Forlani, Giorgio Allemanni, Daniela Marubbi, Maria Pia Pistillo, Aldo Profumo & Massimo Romani. (2017) Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells. Oncotarget 8:21, pages 34896-34910.
Crossref
Crossref
Jennifer D. Moy, Jessica M. Moskovitz & Robert L. Ferris. (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. European Journal of Cancer 76, pages 152-166.
Crossref
Crossref
Federico Garrido, Francisco Ruiz-Cabello & Natalia Aptsiauri. (2016) Rejection versus escape: the tumor MHC dilemma. Cancer Immunology, Immunotherapy 66:2, pages 259-271.
Crossref
Crossref
Ruth J. Davis, Robert L. Ferris & Nicole C. Schmitt. (2016) Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations. Cancers of the Head & Neck 1:1.
Crossref
Crossref
Per thor Straten & Federico Garrido. (2016) Targetless T cells in cancer immunotherapy. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref
Ali Khammanivong, Arunkumar Anandharaj, Xuemin Qian, Jung Min Song, Pramod Upadhyaya, Silvia Balbo, Dipankar Bandyopadhyay, Erin B. Dickerson, Stephen S. Hecht & Fekadu Kassie. (2016)
Transcriptome profiling in oral cavity and esophagus tissues from (
S
)-N′-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis
. Molecular Carcinogenesis 55:12, pages 2168-2182.
Crossref
Crossref
Maria Sophia Mackroth, Annemieke Abel, Christiane Steeg, Julian Schulze zur Wiesch & Thomas Jacobs. (2016) Acute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor Function. PLOS Pathogens 12:11, pages e1005909.
Crossref
Crossref
G.G. Hanna & T. Illidge. (2016) Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?. Clinical Oncology 28:11, pages 726-731.
Crossref
Crossref
Richard C Walshaw, Jamie Honeychurch & Tim M Illidge. (2016) Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?. The British Journal of Radiology 89:1066, pages 20160472.
Crossref
Crossref
Thomas H. P. M. Habets, Tammy Oth, Ans W. Houben, Mirelle J. A. J. Huijskens, Birgit L. M. G. Senden-Gijsbers, Melanie C. A. Schnijderberg, Boudewijn Brans, Ludwig J. Dubois, Philippe Lambin, Marijke De Saint-Hubert, Wilfred T. V. Germeraad, Marcel G. J. Tilanus, Felix M. Mottaghy, Gerard M. J. Bos & Joris Vanderlocht. (2016) Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response. PLOS ONE 11:7, pages e0159515.
Crossref
Crossref
Thomas Carter, Paul Mulholland & Kerry Chester. (2016) Antibody-targeted nanoparticles for cancer treatment. Immunotherapy 8:8, pages 941-958.
Crossref
Crossref
Simon J. Dovedi, Grazyna Lipowska-Bhalla, Stephen A. Beers, Eleanor J. Cheadle, Lijun Mu, Martin J. Glennie, Timothy M. Illidge & Jamie Honeychurch. (2016) Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells. Cancer Immunology Research 4:7, pages 621-630.
Crossref
Crossref
Teresa Fu, Sumaira Z. Aasi & S. Tyler Hollmig. (2016) Management of High-Risk Squamous Cell Carcinoma of the Skin. Current Treatment Options in Oncology 17:7.
Crossref
Crossref
T. Illidge. (2015) Turning Radiotherapy into an Effective Systemic Anti-cancer Treatment in Combination with Immunotherapy. Clinical Oncology 27:12, pages 696-699.
Crossref
Crossref
B. Mennecier. (2015) Immunothérapie dans le cancer bronchique : les inhibiteurs de Checkpoints. Revue des Maladies Respiratoires Actualités 7:4, pages 353-360.
Crossref
Crossref
Julie Jacobs, Evelien Smits, Filip Lardon, Patrick Pauwels & Vanessa Deschoolmeester. (2015) Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect. Journal of Immunology Research 2015, pages 1-16.
Crossref
Crossref